|
|
Archive February 2008
GENITO-URINARY
CANCER |
|
|
What we know
What information do we have about the Eastern Board
area?
What is the result of this on our health locally?
Policies
What is happening in the Eastern Board area?
|
|
| What
we know |
| Cancer is a term for
a group of diseases in which abnormal cells start to develop in
a part of the body. These abnormal malignant cells continue to grow
and then spread (metastasize) through the blood stream and lymphatic
system to other parts of the body such as the liver, bone or brain.
This section looks at the prostate gland in males and the cervix
in females. Cancer of the cervix or neck of the womb can be detected
by a cervical smear test. This is done as part of the national cervical
screening programme. Cancer of the prostate gland in males becomes
more common with increasing age. There are calls for prostate cancer
screening, but the current test gives too many false positive results.
This means that people may undergo unnecessary treatment. Research
continues for a more specific test.
The Northern Ireland Cancer Registry (NICR),
based in Queen's University Belfast, collects information about
cancer in Northern Ireland from a range of sources to get the best
possible estimate of the number and type of cases of cancer in Northern
Ireland. The NICR then provides information about the number of
new cases of cancer each year (incidence) and the number of existing
cases of cancer (prevalence) for all the different cancer types.
The NICR now has data going back to 1993, which enables us to see
the trends in cancer types over time.
Cancer is predominantly a disease of middle age
and old age. According to data from the Northern Ireland Cancer
Registry, half of all patients are aged 68 or over at the time of
diagnosis. Females have a 1-in-8 chance and males a 1-in-6 chance,
of dying of cancer by age 74. One in three people will develop some
type of cancer during their lifetime, but the news is not all bad.
With increasing research and new treatment, many types of cancer
can be cured or at least halted for a time.
The Northern Ireland Cancer Registry reports that in 2001, cancer
of the prostate gland was the third most common cancer in males
in Northern Ireland, representing approximately 12% of male cancers
registered. Half of the cases occurred in men aged over 74 years
and few cases occurred under the age of 50. Prostate cancer was
the second most common cause of cancer death in males.
The Northern Ireland Cancer Registry reports that
in 2001, cancer of the cervix was the twelfth most common cancer
in females in Northern Ireland, representing approximately 2% of
all female cancers registered. Half of the cases were diagnosed
in women below 48 years. Cervical cancer was the twentieth most
common cause of cancer death in females.
Back
to top |
| What information
do we have about the Eastern Board area? |
| In 2005, there were 1591 deaths
from all causes of cancer: 810 males and 781 females. Of these,
87 men died from cancer of the prostate gland. When we look back
to 1991, the rate of death for cancer of the prostate has been decreasing
for men. The rates fluctuate from year to year, because of the small
numbers of deaths, but the trend is downwards. This could be due
to fewer cases occurring, fewer cases diagnosed, earlier diagnosis
leading to better treatment, or a combination of causes.
Cancer of the cervix accounted for 10 deaths in
females in the Eastern Board area. When we look back to 1991, the
rate of death for cancer of the cervix has been decreasing for women.
The rates fluctuate from year to year, because of the small numbers
of deaths, but the trend is downwards. Once again, this could be
due to fewer cases occurring, fewer cases diagnosed, earlier diagnosis
leading to better treatment, or a combination of causes.
|
| What is
the result of this on our health locally? |
Prostate
cancer
There are a number of factors that increase the risk of prostate
cancer. Unfortunately, most of these are factors that cannot be
changed. For example:
 |
The risk of prostate cancer increases
with age; |
 |
Prostate cancer is more likely in those with
a family history of the condition; |
 |
The incidence of prostate cancer is higher
in African Americans (about twice that of white men), and lowest
in Asian and Oriental men. |
Research has found that a diet high in animal fats and proteins
and low levels of selenium may increase the risk of developing prostate
cancer.
What about prostate
cancer screening?
Screening is not a diagnostic test. Finding an abnormal result in
screening may show that a person is at risk of a disease but further
tests will be needed to make an accurate diagnosis. The natural
history of prostate cancer is not fully understood. Prostate cancer
is not a single disease but more a spectrum of diseases ranging
from very aggressive to slow growing tumours, which may not cause
any symptoms or shorten life. Over 90% of prostate cancer deaths
occur in the 65 and over age group. By the age of 80 about 60-70%
of men will have some cancer cells in their prostate. However only
around 1 in 30 of these men will actually die of their prostate
cancer.
PSA (Prostate Specific Antigen) is a substance
made by the prostate gland, which naturally leaks out into the blood
stream. A raised PSA can be an early indication of prostate cancer.
However, other conditions that are not cancer (e.g. enlargement
of the prostate, prostatitis, urinary infection) can also cause
a rise in PSA. Approximately 2 out of 3 men with a raised PSA level
will not have prostate cancer and the PSA test can also miss prostate
cancer.
The National Screening Committee reviews the latest
research evidence to advise the government about whether a screening
test should be introduced, continued, amended or discontinued. The
National Screening Committee currently advises that PSA testing
should not be introduced as a screening test as it produces too
many false positive and false negative tests. Men may then undergo
unnecessary and inappropriate treatment for a disease that they
do not have. Research into a more accurate method of testing is
a priority and ongoing.
Cancer of the cervix
Cancer of the cervix is linked to sexual behaviour. The risk of
developing cancer of the cervix is increased in:
 |
women who have had many sexual
partners |
 |
women who are carrying certain types of Human
Papilloma Virus (HPV) |
 |
women who smoke ( women who smoke are about
twice as likely to develop cervical cancer as non-smokers) |
 |
those who have had their first baby at a
young age |
 |
those who have had more than one pregnancy
(the risk rises with the number of pregnancies) |
 |
women in manual social classes compared with
the risk in women from non-manual social classes |
Using a condom gives some protection against cervical cancer while
long-term use of oral contraceptives increases the risk. However,
the benefits of taking oral contraceptives far outweigh the risks
for the majority of women.
Cancer of the cervix or neck of the womb is usually
detected by a cervical smear test. The woman undergoes an examination
and some cells are taken from the neck of the womb and viewed under
a microscope to see if there are any abnormal cells. Certain types
of abnormal cells are an early warning that cancer may develop.
Women with these abnormal cells require further examination to diagnose
and treat any developing cancer.
Cervical cancer screening
In Northern Ireland all women between the ages
of 20 and 64 are invited to attend every five years for a smear
test. The best way for a woman to reduce the risk of cancer of the
cervix is to ensure that she attends for this test when invited.
For further details of the screening programme please refer to the
cervical screening section of this website.
Back
to top |
| Policies |
| The
Report of the Expert Advisory Group on Cancer, "A Policy Framework
for Commissioning Cancer Services" (the Calman/Hine Report),
1995, recommended a framework for cancer services in England and
Wales.
The Cancer Working Group of the Department of Health
and Social Services (N.I.) built upon the Calman/Hine principles
and in its 1996 report "Cancer Services: Investing for the
Future" (the Campbell Report), described a structure for future
cancer services in Northern Ireland.
The Eastern Health and Social Services Board Palliative
Care Strategic Action Plan 2002 – 2007 was published in 2002
(Palliative Care Services - The Next 5 Years).
It is also important to review and consider recent
guidance:
Regional Guidance:
 |
Review of clinical genetic services
in Northern Ireland |
 |
Gynaecological Cancer Guidelines |
 |
Dermatological Cancer Guidelines |
 |
Haematological Cancer Guidelines |
 |
Endocrine Cancer Guidelines |
 |
Lymphoedema Review |
 |
Review of Clinical Pathology Laboratory Services |
National Institute of Clinical Excellence (NICE)
National Collaborating Centre for Cancer Guidance:
 |
Breast Cancer Service Guidance
(August 2002) |
 |
Urological Cancers Service Guidance (September
2002) |
 |
Haemato-oncology cancer service guidance (October
2003) |
 |
Supportive and Palliative care (March 2004) |
 |
Head and Neck Cancers (Anticipated publication
date October 2004) |
 |
Lung cancer (Anticipated publication date
January 2005) |
 |
Colorectal cancer (Anticipated publication
date January 2005) |
 |
Referral guidelines for suspected cancer (Anticipated
publication date March 2005) |
 |
Prostate cancer ((Anticipated publication
date to be confirmed) |
NHS Modernisation Agency Cancer Services Collaborative
Service Improvement Guides:
 |
Multidisciplinary Team Resource
Guide |
 |
Breast Service Improvement Guide |
 |
Chemotherapy Service Improvement Guide |
 |
Radiotherapy Service Improvement Guide |
 |
Upper GI Service Improvement Guide |
 |
Urology Service Improvement Guide |
 |
Patient and Carer Experience: A Service Improvement
Guide |
Back
to top |
| What is happening
in the Eastern Board area? |
 |
Northern
Ireland Cancer Network
The Eastern Board is currently in the
process of reviewing current cancer service provision in light
of recent regional developments such as the Northern Ireland
Cancer Network (NICaN) and the Regional Cancer Services Framework
group. This process will also review progress against the EHSSB
Cancer Commissioning Group report recommendations. |
 |
Cervical screening
programme
All women between the ages of 20-64 years
of age are invited, either by the central screening office or
by their own General Practitioners, to have the cervical smear
test carried out. Although the regional programme operates at
five-year intervals, many individual practitioners offer to
screen women every three years. |
 |
In 1997 the Eastern Health and Social
Services Board (EHSSB)
convened a multi-agency Cancer Commissioning Group, with the
remit to oversee implementation of policy on the prevention
and treatment of cancer for Eastern Board residents. Seven
Cancer Commissioning sub-groups were established to inform
this process:
 |
breast cancer; |
 |
lung cancer; |
 |
gastrointestinal cancers, including
colorectal; |
 |
gynaecological cancers; |
 |
urological cancers; |
 |
palliative care; |
 |
cancer prevention. |
|
 |
In March 1998, the Eastern Board established
the EHSSB Cancer
Implementation Group which was tasked to take forward the recommendations
from the Cancer Commissioning Group report. Site-specific implementation
subgroups were (re)convened to take forward this work in phases. |
 |
Published in August, the EHSSB
Cancer Commissioning Group report described the recommendations
for future cancer services for Eastern Board residents. The
report covered all aspects of care from prevention through to
cure and palliation and outlined the strategic and resource
implications of the proposed service models. |
 |
The Eastern Board area contains the Cancer
Centre and two Cancer Units at the Belfast City Hospital and
the Ulster Hospital. However, given the varied initial clinical
presentation of malignant disease, general specialties within
all acute Eastern Board hospitals continue to have an important
role in investigation and diagnosis, local treatment where appropriate,
and referral onward as part of multidisciplinary treatment. |
 |
Regional Cancer Centre
Construction of the new Regional Cancer Centre building on the
Belfast City Hospital site commenced in 2002. The work is progressing
well and is on schedule, with the building expected to be opened
for clinical service at the start of 2006. |
Back to top
|
For further information on this topic please contact us at publichealth@ehssb.n-i.nhs.uk
Eastern Health and Social Services Board Champion
House, 12-22 Linenhall Street, Belfast BT2 8BS Telephone: (028)
9032 1313 Fax: (028) 9055 3681 Text Phone:(028) 9032 4980 Website:
www.ehssb.org
E-mail: pr@ehssb.n-i.nhs.uk Site designed by areema.co.uk |
| |
|